Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Rapid Communications in Mass Spectrometry : RCM|April 23, 2002
Characterization and sequence confirmation of unnatural amino acid containing peptide libraries using electrospray ionization mass spectrometryJef Rozenski, Patrick Chaltin, Arthur Van Aerschot, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Comparison of library screening techniques used in the development of dsDNA ligandsPatrick Chaltin, Filip Borgions, Arthur Van Aerschot, et al.Analytical Biochemistry|February 23, 2011
Development of a high-throughput screening assay for the discovery of small-molecule SecA inhibitorsKenneth Segers, Hugo Klaassen, Anastasios Economou, et al.Expert Opinion on Therapeutic Patents|March 27, 2014
LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 - 2014)Jonas Demeulemeester, Patrick Chaltin, Arnaud Marchand, et al.Viruses|December 23, 2023
A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus InhibitorsXinyu Wang, Winston Chiu, Hugo Klaassen, et al.Analytical Chemistry|April 2, 2005
Simulation of evolution-selected propeptide by high-throughput selection of a peptidomimetic inhibitor on a capillary DNA sequencer platformJialiang Hu, Pierre Fiten, Philippe E Van den Steen, et al.Current Medicinal Chemistry|June 13, 2009
Antifungal carbazolesKarin Thevissen, Arnaud Marchand, Patrick Chaltin, et al.Molecular Cancer Therapeutics|April 13, 2012
Identification and characterization of MEL-3, a novel AR antagonist that suppresses prostate cancer cell growthChristine Helsen, Arnaud Marchand, Patrick Chaltin, et al.Bioorganic & Medicinal Chemistry|September 6, 2002
New dsDNA binding unnatural oligopeptides with pyrimidine selectivityZhenyu Zhang, Patrick Chaltin, Arthur Van Aerschot, et al.Antiviral Research|March 26, 2022
Identification of novel Ebola virus inhibitors using biologically contained virusBert Vanmechelen, Joren Stroobants, Winston Chiu, et al.Pageof 7